Location: Home
  • search
  • go
  • Relate News
  • 1/17/2020Chinese Pharmaceutical Industry Growth Continued to Slow in 2019
  • 1/17/2020Chinese Birthrate Falls To Lowest Level In 70 Years
  • 1/16/2020Celltrion to Build Biosimilar Plant in China
  • 1/16/2020Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar
  • 1/16/2020Wuxi Biologics Strikes Deal to Take Over A Bayer Plant in Germany
  • 1/16/2020U.S.-China Phase 1 Deal Hands Pharma MNCs A Major IPR Win
  • 1/16/2020Drugmakers Brace for China's Biggest-Ever Round of Price Cuts
  • 1/16/2020China Issues Notice for Implementing National Level Centralized Drug P...
  • 1/15/2020Review of Chinese Drug Registration Applications and Approvals in 2019
  • 1/15/2020MNC New Product Launches in China Down Slightly to 37 During 2019
  • 1/15/2020National Healthcare Security Working Conference Lays Out Major Tasks i...
  • 1/15/2020NHC Solicits Comments on the Interim Rules for National Level Shortage...
  • 1/15/2020GenScript and Genopis Partner to Manufacture Plasmids
  • 1/15/2020U.S. and China Inks Phase One Trade Deal
  • 1/15/2020US, China Agree To Protect Patents, Fight Trade Secret Abuse in Phase ...
  • 1/14/2020NMPA/Yaozh Publish Analytical Report on Approved GQCE Reference Drugs
  • 1/14/2020Gilead Launches HIV Combo Drug Biktarvy in China
  • 1/14/2020China Adds Over 6,000 TCM Clinics in 2019
  • 1/14/2020Ambrx and Sino Biopharma Announce Collaboration to Develop Two Next-Ge...
  • 1/14/2020HitGen Enters into DEL-Based Drug Discovery Partnership with Kymera
  • 1/14/2020Chi-Med Initiates a PII Trial of Surufatinib in Combo with Toripalimab...
  • 1/13/2020BeiGene In-licences Candidates from EUSA Pharma
  • 1/13/2020NMPA Issues Notice on Matters Relating to API Registration Dossier
  • 1/13/2020HRA Pharma Expands in China with Joint Venture
  • 1/11/2020Recent Executive Moves
  • 1/11/2020NMPA Clears Phase 3 Trial for SB12, Samsung Bioepis' Biosimilar Eculiz...
  • 1/11/2020Eisai Launches Anticancer Agent Halaven in China
  • 1/10/2020PPD Expanding Capabilities in China
  • 1/10/2020Shield Therapeutics Licenses China Right of Lead Product to Ask Pharma
  • 1/10/2020NMPA Publicizes List of Reference Formulations for Generic Drug Equiva...
  • Page:251/774 Total number of articles:23207: [First][<<] [249] [250] [251] [252] [253] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group